No Jewellery, Cellphone Use In ICU: Advisory To Health Workers

New Delhi: Healthcare workers should remove all types of jewellery below the elbow while on duty, Centre said in a fresh directive.

In the directive issued to heads of all central govt run hospitals, the director general of health services (DGHS) has also stressed the need to develop and enforce a policy to restrict use of mobile phones in patient areas and critical zones such as ICUs, HDUs, post-operative wards and operation rooms.

According to DGHS Atul Goel, there is substantial evidence that wearing hand jewellery below the elbow increases total skin micro-organism counts. “Use of mobile phones, while on duty especially in critical areas like ICUs, HDUs, post-operative wards and operation theatres, pose infection risks,” he said in his letter sent out on April 9.

He has suggested that respective hospitals can revise their SOPs (standard operating procedures) on hand hygiene and specifically mention where wristwatches are permitted. Similar guidelines are applicable in other leading hospitals globally as well, said a senior doctor.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre